19-55141344-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003283.6(TNNT1):​c.193-42C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.039 in 1,498,868 control chromosomes in the GnomAD database, including 1,242 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 98 hom., cov: 32)
Exomes 𝑓: 0.040 ( 1144 hom. )

Consequence

TNNT1
NM_003283.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0950

Publications

3 publications found
Variant links:
Genes affected
TNNT1 (HGNC:11948): (troponin T1, slow skeletal type) This gene encodes a protein that is a subunit of troponin, which is a regulatory complex located on the thin filament of the sarcomere. This complex regulates striated muscle contraction in response to fluctuations in intracellular calcium concentration. This complex is composed of three subunits: troponin C, which binds calcium, troponin T, which binds tropomyosin, and troponin I, which is an inhibitory subunit. This protein is the slow skeletal troponin T subunit. Mutations in this gene cause nemaline myopathy type 5, also known as Amish nemaline myopathy, a neuromuscular disorder characterized by muscle weakness and rod-shaped, or nemaline, inclusions in skeletal muscle fibers which affects infants, resulting in death due to respiratory insufficiency, usually in the second year. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNNT1 Gene-Disease associations (from GenCC):
  • nemaline myopathy 5
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • nemaline myopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • nemaline myopathy 5C, autosomal dominant
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 19-55141344-G-C is Benign according to our data. Variant chr19-55141344-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 259030.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0337 (5138/152288) while in subpopulation NFE AF = 0.0419 (2850/68012). AF 95% confidence interval is 0.0406. There are 98 homozygotes in GnomAd4. There are 2537 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 98 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNNT1NM_003283.6 linkc.193-42C>G intron_variant Intron 7 of 13 ENST00000588981.6 NP_003274.3 P13805-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNNT1ENST00000588981.6 linkc.193-42C>G intron_variant Intron 7 of 13 1 NM_003283.6 ENSP00000467176.1 P13805-1

Frequencies

GnomAD3 genomes
AF:
0.0338
AC:
5140
AN:
152170
Hom.:
98
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0190
Gnomad AMI
AF:
0.0877
Gnomad AMR
AF:
0.0358
Gnomad ASJ
AF:
0.0432
Gnomad EAS
AF:
0.0177
Gnomad SAS
AF:
0.0135
Gnomad FIN
AF:
0.0433
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0419
Gnomad OTH
AF:
0.0415
GnomAD2 exomes
AF:
0.0332
AC:
8310
AN:
250398
AF XY:
0.0335
show subpopulations
Gnomad AFR exome
AF:
0.0180
Gnomad AMR exome
AF:
0.0218
Gnomad ASJ exome
AF:
0.0414
Gnomad EAS exome
AF:
0.0168
Gnomad FIN exome
AF:
0.0402
Gnomad NFE exome
AF:
0.0441
Gnomad OTH exome
AF:
0.0401
GnomAD4 exome
AF:
0.0396
AC:
53320
AN:
1346580
Hom.:
1144
Cov.:
21
AF XY:
0.0390
AC XY:
26400
AN XY:
676308
show subpopulations
African (AFR)
AF:
0.0207
AC:
645
AN:
31204
American (AMR)
AF:
0.0220
AC:
982
AN:
44546
Ashkenazi Jewish (ASJ)
AF:
0.0399
AC:
1012
AN:
25352
East Asian (EAS)
AF:
0.0229
AC:
898
AN:
39140
South Asian (SAS)
AF:
0.0160
AC:
1344
AN:
83918
European-Finnish (FIN)
AF:
0.0399
AC:
2116
AN:
53014
Middle Eastern (MID)
AF:
0.0527
AC:
292
AN:
5540
European-Non Finnish (NFE)
AF:
0.0435
AC:
43843
AN:
1007242
Other (OTH)
AF:
0.0386
AC:
2188
AN:
56624
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
2460
4921
7381
9842
12302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1566
3132
4698
6264
7830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0337
AC:
5138
AN:
152288
Hom.:
98
Cov.:
32
AF XY:
0.0341
AC XY:
2537
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0190
AC:
788
AN:
41570
American (AMR)
AF:
0.0357
AC:
547
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0432
AC:
150
AN:
3470
East Asian (EAS)
AF:
0.0180
AC:
93
AN:
5176
South Asian (SAS)
AF:
0.0137
AC:
66
AN:
4826
European-Finnish (FIN)
AF:
0.0433
AC:
459
AN:
10610
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.0419
AC:
2850
AN:
68012
Other (OTH)
AF:
0.0411
AC:
87
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
268
536
805
1073
1341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0385
Hom.:
28
Bravo
AF:
0.0326
Asia WGS
AF:
0.0120
AC:
44
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.030
DANN
Benign
0.46
PhyloP100
-0.095
PromoterAI
-0.015
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73060953; hg19: chr19-55652712; API